- Citations, last 5 years
- 34.1k
- Works, last 5 years
- 1 655
- h-index
- 548
- Scientists listed
- 0
- Grants since 2016
- 573
Grants received
2020–2025 · research · R01
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2020–2024 · research · R21
Targeting Tat/TAR interactions with the superelongation complex to develop novel treatments for HIV/AIDS
Ursula Schulze-Gahmen · Gladstone Institutes · funded by National Institutes of Health
2020–2024 · research · R01
Aortic Valve Disease: Mechanisms and Therapeutic Approaches
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Modeling intestinal dysfunction in HIV infection with organoid technology
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Resolving single-cell brain regulatory elements with bulk data supervised models
Katherine S. Pollard · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
Ken Nakamura · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · grant · DP1
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2020–2024 · research · R01
Aortic Valve Disease: Mechanisms and Therapeutic Approaches
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Study the Protective Roles of ApoE2 in Alzheimer's Disease Using Reprogrammed Isogenic Cells
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2020–2024 · research · R01
Modeling intestinal dysfunction in HIV infection with organoid technology
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Genetic determinants of 4D genome folding in human cardiac development
Benoit Gaetan Bruneau · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
Ken Nakamura · Gladstone Institutes · funded by National Institutes of Health
2020 · fellowship · Postdoctoral Fellowship
The role of Dach1-induced arteriogenesis on structural and functional neurovascular recovery after cerebral stroke
Andrew Hsiu-Hao Chang · Gladstone Institutes · funded by American Heart Association
2020–2025 · cooperative agreement · U01
Genetic determinants of 4D genome folding in human cardiac development
Benoit Gaetan Bruneau · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · grant · DP1
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Aortic Valve Disease: Mechanisms and Therapeutic Approaches
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2020–2024 · research · R01
Modeling intestinal dysfunction in HIV infection with organoid technology
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2020–2022 · research · R21
Targeting Tat/TAR interactions with the superelongation complex to develop novel treatments for HIV/AIDS
Ursula Schulze-Gahmen · Gladstone Institutes · funded by National Institutes of Health
2020–2026 · research · R01
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
Ken Nakamura · Gladstone Institutes · funded by National Institutes of Health
2020 · research · AARF
Understanding how APP and ApoE4 Converge to Modulate Glucose in AD models
Huihui Li · Gladstone Institutes · funded by Alzheimer's Association
2020–2021 · fellowship · Postdoctoral Fellowship
Controlling Mitochondria to Engineer Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Serah Kang · Gladstone Institutes · funded by American Heart Association
2020–2022 · fellowship · F32
State-dependent regulation of mesolimbic dopamine and ventral striatal neuron activity
Aphroditi Mamaligas · Gladstone Institutes · funded by National Institutes of Health
2020–2022 · research · R21
Evolving CRISPR-based platforms for the discovery of Alzheimer relevant neurodegenerative pathways
Lennart Mucke · Gladstone Institutes · funded by National Institutes of Health
2020–2024 · research · R01
Modeling intestinal dysfunction in HIV infection with organoid technology
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Study the Protective Roles of ApoE2 in Alzheimer's Disease Using Reprogrammed Isogenic Cells
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · grant · DP1
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
Ken Nakamura · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · research · R01
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2020–2022 · research · R21
The role of arteriogenesis on structural and functional neurovascular recovery after cerebral stroke
Jeanne T Paz · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · grant · DP1
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · grant · DP1
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · grant · DP1
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2020–2025 · grant · DP1
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2019–2021 · research · R56
Development of a Technology Platform for Engineering Single-Administration HIV Therapeutics
Leor S Weinberger · Gladstone Institutes · funded by National Institutes of Health
2019–2023 · career development · K99
Functional Alterations of Parvalbumin Interneurons Contributing to Abnormal Network Activity in Alzheimer's Disease Mouse Models
Keran Ma · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · research · R01
Deciphering molecular pathways of inhibitory interneuron dysfunction in Alzheimer's disease
Jorge J Palop · Gladstone Institutes · funded by National Institutes of Health
2019–2023 · research · R01
Apolipoprotein E4-related Electrophysiological and Metabolic Impairments in Aging and Alzheimer's Disease
Misha Yuri Zilberter · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · research · R01
Deciphering molecular pathways of inhibitory interneuron dysfunction in Alzheimer's disease
Jorge J Palop · Gladstone Institutes · funded by National Institutes of Health